Editorial policy
GLP-1 Savers publishes price-first deal reviews. Every price, coverage claim and savings figure is tied to a program's public disclosures or official drug labeling, and we record the ongoing rate you pay after any intro month — not the teaser headline. We earn a commission when you start treatment through some links on this site, at no extra cost to you, and a program that's a poor deal is scored like one whether it pays us or not. Prices move fast; entries are dated, re-checked on a rolling basis, and corrections are made promptly and noted.
Who applies that policy, and how this site is funded, is set out on our about page; the commercial relationships themselves are itemized in the disclosure. Every scored program lands on one of the price rankings, and the rubric behind the score is published in full in the methodology.